Leyuan Xu

Yale University

$2,035,306

Attributed

$2,035,306

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $646K · FY2019–25

$1M$750K$500K$250K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,035,306 · 3

By mechanism

R01$1,090,760 · 1

K01$698,321 · 1

R03$246,225 · 1

Top collaborators

No co-investigators on record.

Most similar at Yale University

Same institution · by research overlap

Lloyd G Cantley$26,240,423
Jack A Elias$29,308,180
Priti Kumar$9,682,784
Stefan Somlo$20,826,249
Akiko Iwasaki$25,435,081

Others in their field

Other Emerging Leaders on “Fibrosis”

Vera Hoffman · Reveal Pharma$12,481,658
Thomas Dick · Rbhs-New Jersey Medical School$11,012,954
Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,153,043
Ionut Bebu · George Washington University$9,972,097
Barbara Halina Braffett · George Washington University$9,972,097
Jennifer Cohen Price · University Of California, San Francisco$9,725,541

Research focus

FibrosisFailureRepairedReceptorReperfusion InjuryChronic Kidney FailureMacrophageKidney FibrosisMouse ModelPlayInnovationIn VitroDendrimersTubular FormationIn VivoCellsKidneyDisease ProgressionInjuryMannose ReceptorAcute Renal Failure With Renal Papillary NecrosisChronic InfectionInterestContralateral